Rise in number of road accidents and burn incidences boosts growth of the market. Road accidents and burn cases are responsible for scar formation. For instance, according to the National Highway Traffic Safety Administration (NHTSA) of the U.S. Department of Transportation in 2020, 38,680 people died in motor vehicle traffic crashes. in addition, some accients requires surgical operation which further contributes in the growth of scar treatment market.
Furthermore, increase in demand for cosmetic surgeries to improve appearance and restore scar marks propel growth of the market. For instance, according to the International Society of Aesthetic Plastic Surgery (ISAPS) survey, in 2020 around 10,129,528 cosmetic surgical procedures were carried worldwide.
Moreover, increase in R&D activities and novel product launches in the market by key players boost the market growth. For instance, in September, 2021, SkinCeuticals, a leading medical skincare brand, launched Advanced scar control gel, specifically formulated for different types of scars and ideal complement to post-procedure scar care for procedures such as Mohs surgery and scar revision surgery. Furthermore, rise in number of hospitals and improvements in healthcare infrastructure further contributes toward the market growth. However, high cost of scar treatment limits growth of the market.
The scar treatment market is segmented on the basis of scar type, product, end user, and region. By scar type, the market is divided into atrophic scars, hypertrophic & keloid scars, contractures, and stretch marks. By product, it is divided into topical, laser-based treatment, and others. By end user, it is divided into hospitals, clinics, and home care. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the scar treatment market analysis from 2021 to 2031 to identify the prevailing scar treatment market opportunity.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the scar treatment market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global scar treatment market size.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global scar treatment market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Scar Type
- Atrophic Scar
- Hypertrophic and Keloid Scar
- Contractures
- Stretch Marks
By Product
- Topical
- Laser based treatment
- Others
By End User
- Hospitals
- Clinics
- Home Care
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Avita Medical Limited
- Bausch Health Companies Inc.
- Cynosure, Inc.
- hra pharma
- Mölnlycke Health Care AB
- Polytech Health & Aesthetics GmbH
- Sientra, Inc.
- sisram inc
- Smith and Nephew plc.
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
Executive Summary
According to this report titled, 'Scar Treatment Market,' the scar treatment market size was valued at $13.1 billion in 2021, and is estimated to reach $32.4 billion by 2031, growing at a CAGR of 9.4% from 2022 to 2031.Scarring is the process of external epidermal layer repair. Thus, scars result naturally as part of normal healing process in human body. Scars occur exactly at the site of wounds and nearby areas resulting in dark red fibrous tissue, which gradually becomes lighter in color. Scar treatment such as anti-scar gels and laser treatment are used to remove scar marks to enhance appearance.
Rise in demand for cosmetic corrections and availabilities of different anti-scar treatments drive growth of the market. Furthermore, rise in incidences of stretch marks, owing to heavy weight training and obesity drives demand for scar treatment. In addition, women have stretch marks owing to cesarean child delivery, which further contributes toward growth of the Scar Treatment Industry. For instance, according to the Centers for Disease Control and Prevention (CDC), in 2020, cesarean delivery rate increased to 31.8%.
Furthermore, factors such as advancements in Scar Treatment Industry, increase in R&D activities, rise in number of hospitals and cosmetic clinics deives the Scar Treatment Market Growth. For instance, in April 2021, Pharmaxis, Australian pharmaceutical research company, in collaboration with the University of Western Australia (UWA) to start a world-first clinical trial to investigate a cream to stop scar forming after trauma, particularly following burn injuries. Furthermore, rise in awareness regarding scar treatment contributes toward growth of the scar treatment market.
Increase in prevalence of injuries and burn cases drive growth of the market. Infectious wounds tend to take longer healing time, which results in hypertrophic scar formation. In addition, rise in clinical trials for development of novel scar treatment contributes in growth of the market. For instance, in December 2020, according to a report published by Springer Nature, a global scientific publisher, intralesional 1470 nm bare-fiber diode laser shows promising results for treatment of hypertrophic scars. Furthermore, rise in trend of skin piercing further drives growth of the market. Skin piercing leads to formation of keloids. Thus, prevalence of wound injuries and R&D for novel treatment of hypertrophic scars boost growth of the market
The scar treatment market is segmented into by scar type, product, end user, and region.
On the basis of scar type, the market is divided into atrophic scar, hypertrophic & keloid scar, contractures, and stretch marks. The atrophic scar segment dominated the market in 2021, and is expected to dominate during the forecast period, owing to increase in prevalence of acne and chicken pox.
Depending on product, the market is classified into topical, laser-based treatment, and others. The topical segment have the largest Scar Treatment Market Share in 2021, and is expected to dominate during the forecast period, owing to easy availability of topical products and rise in consciousness regarding aesthetic appearance.
By end user, it is divided into hospitals, clinics, and home care. The home care segment dominated the Scar Treatment Market Forecast in 2021, and is expected to continue the same during the forecast period, owing to rise in number of retail pharmacies and high incidences of facial scars.
North America accounted for a majority of the global scar treatment market share in 2021, and is anticipated to remain dominant during the forecast period. This is attributed to presence of key players in the region. Asia-Pacific is anticipated to witness lucrative growth, owing to increase in demand for aesthetic looks.
KEY FINDINGS OF STUDY
- On the basis of scar type, the atrophic scar segment was the highest contributor to the market in 2021.
- Depending on product, the topical segment was the highest contributor to the market in 2021.
- By end user, hospital segment dominates the market in 2021.
- Region wise, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
Companies Mentioned
- Avita Medical Limited
- Bausch Health Companies Inc.
- Cynosure, Inc.
- hra pharma
- Mölnlycke Health Care AB
- Polytech Health & Aesthetics GmbH
- Sientra, Inc.
- sisram inc
- Smith and Nephew plc.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...